Progesterone Receptor Negative Recruiting Phase 3 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0038639 (Progesterone Receptor Negative)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs